i don't see any reason to blame novartis. from other posts it's clear that the FDA put off all meetings for a month and i personally wouldn't blame them for leaving town for awhile and not making any decisions. It's my understanding that novartis was expecting a reply but has not received it. I also don't think that the FDA can say anything publicly on this at this pointin theprocess.tom